Myovant Sciences Ltd. Revenue
Myovant Sciences Ltd. reported Revenue of $100.23 million for the 3-month period ending 2022-12-31, per its 10-Q filed 2023-01-26.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2023-01-26
- Myovant Sciences Ltd. revenues for the quarter ending 2022-12-31 was $100.23M, a 84.11% increase year-over-year.
- Myovant Sciences Ltd. revenues for the quarter ending 2022-09-30 was $104.82M, a 34.56% increase year-over-year.
- Myovant Sciences Ltd. revenues for the quarter ending 2022-06-30 was $116.49M, a 183.69% increase year-over-year.
- Myovant Sciences Ltd. revenues for the quarter ending 2022-03-31 was $57.57M, a 133.96% increase year-over-year.
- Myovant Sciences Ltd. revenues for fiscal 2022 was $230.97M, a 289.39% increase from fiscal 2021.
- Myovant Sciences Ltd. revenues for fiscal 2021 was $59.32M.
- Myovant Sciences Ltd. revenues for fiscal 2020 was $0.00.
- Myovant Sciences Ltd. revenues for fiscal 2019 was $0.00.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2022-12-31 | $100.23M 10-Q · filed 2023-01-26 | $205.05M derived: sum of 2 quarters · filed 2023-01-26 | $321.55M 10-Q · filed 2023-01-26 | $379.11M derived: sum of 4 quarters · filed 2023-01-26 |
| 2022-09-30 | $104.82M 10-Q · filed 2022-10-26 | $221.32M 10-Q · filed 2022-10-26 | $278.88M derived: sum of 3 quarters · filed 2022-10-26 | $333.32M derived: sum of 4 quarters · filed 2023-01-26 |
| 2022-06-30 | $116.49M 10-Q · filed 2022-07-27 | $174.06M derived: sum of 2 quarters · filed 2022-07-27 | $228.50M derived: sum of 3 quarters · filed 2023-01-26 | $306.40M derived: sum of 4 quarters · filed 2023-01-26 |
| 2022-03-31 | $57.57M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-11 | $112.01M derived: sum of 2 quarters · filed 2023-01-26 | $189.91M derived: sum of 3 quarters · filed 2023-01-26 | $230.97M 10-K · filed 2022-05-11 |
| 2021-12-31 | $54.44M 10-Q · filed 2023-01-26 | $132.34M derived: sum of 2 quarters · filed 2023-01-26 | $173.41M 10-Q · filed 2023-01-26 | $198.01M derived: sum of 4 quarters · filed 2023-01-26 |
| 2021-09-30 | $77.90M 10-Q · filed 2022-10-26 | $118.97M 10-Q · filed 2022-10-26 | $143.57M derived: sum of 3 quarters · filed 2022-10-26 | $144.95M derived: sum of 4 quarters · filed 2022-10-26 |
| 2021-06-30 | $41.06M 10-Q · filed 2022-07-27 | $65.67M derived: sum of 2 quarters · filed 2022-07-27 | $67.05M derived: sum of 3 quarters · filed 2022-07-27 | $67.05M derived: sum of 4 quarters · filed 2022-07-27 |
| 2021-03-31 | $24.61M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-11 | $25.98M derived: sum of 2 quarters · filed 2022-05-11 | $25.98M derived: sum of 3 quarters · filed 2022-05-11 | $59.32M 10-K · filed 2022-05-11 |
| 2020-12-31 | $1.38M 10-Q · filed 2022-01-26 | $1.38M derived: sum of 2 quarters · filed 2022-01-26 | $34.71M 10-Q · filed 2022-01-26 | $34.71M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-09-30 | $0.00 10-Q · filed 2021-10-26 | $33.33M 10-Q · filed 2021-10-26 | $33.33M derived: sum of 3 quarters · filed 2022-05-11 | $33.33M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-06-30 | $33.33M 10-Q · filed 2021-07-28 | $33.33M derived: sum of 2 quarters · filed 2022-05-11 | $33.33M derived: sum of 3 quarters · filed 2022-05-11 | |
| 2020-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-11 | $0.00 derived: sum of 2 quarters · filed 2022-05-11 | $0.00 10-K · filed 2022-05-11 | |
| 2019-12-31 | $0.00 10-Q · filed 2021-02-11 | $0.00 10-Q · filed 2021-02-11 | ||
| 2019-03-31 | $0.00 10-K · filed 2021-05-11 |